{"pageContent": "Purpose of review: The estimated disease-free survival rates are approximately equivalent across standard treatments for localized prostate cancer. We aim to review the efforts being made to reduce posttreatment erectile dysfunction, a major morbidity of these therapies.", "metaData": {"source": "Development and validation of the korean version of expanded prostate cancer index composite: questionnaire assessing health-related quality of life after prostate cancer treatment\nhttps://pubmed.ncbi.nlm.nih.gov/20856644/"}}